Omics-based biomarkers discovery for Alzheimer's disease

Molinuevo JL, Ayton S, Batrla R et al (2018) Current state of Alzheimer’s fluid biomarkers. Acta Neuropathol 136(6):821–853. https://doi.org/10.1007/s00401-018-1932-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scheltens P, De Strooper B, Kivipelto M et al (2021) Alzheimer’s disease. Lancet (London, England) 397(10284):1577–1590. https://doi.org/10.1016/S0140-6736(20)32205-4

Article  CAS  Google Scholar 

Millan MJ (2017) Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer’s disease: an integrative review. Prog Neurobiol. https://doi.org/10.1016/j.pneurobio.2017.03.004

Article  PubMed  Google Scholar 

Bishop NA, Lu T, Yankner BA (2010) Neural mechanisms of ageing and cognitive decline. Nature 464(7288):529–535. https://doi.org/10.1038/nature08983

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang EF, Hou Y, Palikaras K et al (2019) Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. Nat Neurosci 22(3):401–412. https://doi.org/10.1038/s41593-018-0332-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lautrup S, Sinclair DA, Mattson MP et al (2019) NAD in brain aging and neurodegenerative disorders. Cell Metab 30(4):630–655. https://doi.org/10.1016/j.cmet.2019.09.001

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peña-Bautista C, Baquero M, Vento M et al (2019) Omics-based biomarkers for the early Alzheimer disease diagnosis and reliable therapeutic targets development. Curr Neuropharmacol 17(7):630–647. https://doi.org/10.2174/1570159X16666180926123722

Article  PubMed  PubMed Central  Google Scholar 

Hampel H, Nisticò R, Seyfried NT et al (2021) Omics sciences for systems biology in Alzheimer’s disease: state-of-the-art of the evidence. Ageing Res Rev. https://doi.org/10.1016/j.arr.2021.101346

Article  PubMed  Google Scholar 

Pimenova AA, Raj T, Goate AM (2018) Untangling genetic risk for Alzheimer’s disease. Biol Psychiat 83(4):300–310. https://doi.org/10.1016/j.biopsych.2017.05.014

Article  CAS  PubMed  Google Scholar 

Mostafavi S, Gaiteri C, Sullivan SE et al (2018) A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer’s disease. Nat Neurosci 21(6):811–819. https://doi.org/10.1038/s41593-018-0154-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wesseling H, Mair W, Kumar M et al (2020) Tau PTM profiles identify patient heterogeneity and stages of Alzheimer’s disease. Cell. https://doi.org/10.1016/j.cell.2020.10.029

Article  PubMed  PubMed Central  Google Scholar 

Mahajan UV, Varma VR, Griswold ME et al (2020) Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: a targeted metabolomic and transcriptomic study. PLoS Med 17(1):e1003012. https://doi.org/10.1371/journal.pmed.1003012

Article  CAS  PubMed  PubMed Central  Google Scholar 

Márquez F, Yassa MA (2019) Neuroimaging biomarkers for Alzheimer’s disease. Mol Neurodegener 14(1):21. https://doi.org/10.1186/s13024-019-0325-5

Article  PubMed  PubMed Central  Google Scholar 

Zetterberg H, Burnham SC (2019) Blood-based molecular biomarkers for Alzheimer’s disease. Mol Brain 12(1):26. https://doi.org/10.1186/s13041-019-0448-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schonhaut DR, McMillan CT, Spina S et al (2017) F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: a multicenter study. Ann Neurol 82(4):622–634. https://doi.org/10.1002/ana.25060

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mapstone M, Cheema AK, Fiandaca MS et al (2014) Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med 20(4):415–418. https://doi.org/10.1038/nm.3466

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang M, Beckmann ND, Roussos P et al (2018) The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer’s disease. Sci Data. https://doi.org/10.1038/sdata.2018.185

Article  PubMed  PubMed Central  Google Scholar 

Serrano-Pozo A, Das S, Hyman BT (2021) APOE and Alzheimer’s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol 20(1):68–80. https://doi.org/10.1016/S1474-4422(20)30412-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Rojas I, Moreno-Grau S, Tesi N et al (2021) Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores. Nat Commun 12(1):3417. https://doi.org/10.1038/s41467-021-22491-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cuperlovic-Culf M, Badhwar A (2020) Recent advances from metabolomics and lipidomics application in Alzheimer’s disease inspiring drug discovery. Expert Opin Drug Discov 15(3):319–331. https://doi.org/10.1080/17460441.2020.1674808

Article  CAS  PubMed  Google Scholar 

Kunkle BW, Grenier-Boley B, Sims R et al (2019) Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat Genet 51(3):414–430. https://doi.org/10.1038/s41588-019-0358-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jansen IE, Savage JE, Watanabe K et al (2020) Author Correction: Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat Genet 52(3):354. https://doi.org/10.1038/s41588-019-0573-x

Article  CAS  PubMed  Google Scholar 

Bertram L, Tanzi RE (2019) Alzheimer disease risk genes: 29 and counting. Nat Rev Neurol 15(4):191–192. https://doi.org/10.1038/s41582-019-0158-4

Article  PubMed  Google Scholar 

Dourlen P, Kilinc D, Malmanche N et al (2019) The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? Acta Neuropathol 138(2):221–236. https://doi.org/10.1007/s00401-019-02004-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma Y, Jun GR, Zhang X et al (2019) Analysis of whole-exome sequencing data for Alzheimer disease stratified by APOE genotype. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2019.1456

Article  PubMed  PubMed Central  Google Scholar 

Schwartzentruber J, Cooper S, Liu JZ et al (2021) Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer’s disease risk genes. Nat Genet 53(3):392–402. https://doi.org/10.1038/s41588-020-00776-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wightman DP, Jansen IE, Savage JE et al (2021) A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease. Nat Genet 53(9):1276–1282. https://doi.org/10.1038/s41588-021-00921-z

Article  CAS  PubMed  Google Scholar 

Kunkle BW, Grenier-Boley B, Sims R et al (2019) Author Correction: genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet 51(9):1423–1424. https://doi.org/10.1038/s41588-019-0495-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaiteri C, Mostafavi S, Honey CJ et al (2016) Genetic variants in Alzheimer disease - molecular and brain network approaches. Nat Rev Neurol 12(7):413–427. https://doi.org/10.1038/nrneurol.2016.84

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kleineidam L, Chouraki V, Próchnicki T et al (2020) PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment. Acta Neuropathol 139(6):1025–1044. https://doi.org/10.1007/s00401-020-02138-6

Article  PubMed  PubMed Central  Google Scholar 

Cuddy LK, Prokopenko D, Cunningham EP et al (2020) Aβ-accelerated neurodegeneration caused by Alzheimer’s-associated variant R1279Q is rescued by angiotensin system inhibition in mice. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aaz2541

Article  PubMed  Google Scholar 

Prokopenko D, Lee S, Hecker J et al (2022) Region-based analysis of rare genomic variants in whole-genome sequencing datasets reveal two novel Alzheimer’s disease-associated genes: DTNB and DLG2. Mol Psychiatry. https://doi.org/10.1038/s41380-022-01475-0

Article  PubMed  PubMed Central  Google Scholar 

Neumann A, Kucukali F, Bos I et al (2022) Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation. Mol Psychiatry. https://doi.org/10.1038/s41380-022-01437-6

Article  PubMed  PubMed Central  Google Scholar 

Ming C, Wang M, Wang Q et al (2021) Whole genome sequencing-based copy number variations reveal novel pathways and targets in Alzheimer’s disease. Alzheimers Dement. https://doi.org/10.1002/alz.12507

Article 

留言 (0)

沒有登入
gif